TB remains a major global public health problem and progress in reducing the burden of disease falls far short of 2030 targets in most parts of the world. Nonetheless, after setbacks during the COVID-19 pandemic, most indicators are moving in the right direction and there are regional and country success stories. However, changes in the funding landscape threaten this progress.

About 1.23 million people died from TB in 2024, including 150,000 people living with HIV. This is a marginal improvement from the 1.25 million deaths in 2023, but highlights TB is still the leading infectious disease killer. An estimated 10.7 million people fell ill with TB in 2024, a reduction from 10.8 million in 2023. In 2024 2.3 million people with TB were missed, which means treatment coverage reached a record 78%. Among these, 8.3 million new cases were formally diagnosed, the highest since global monitoring began.